Clinical Trials Barriers
Patient enrollment in clinical trials is a major issue, however, the lack of ethnic minorities can hinder the advancement of medical science to combat diseases.
Clinical trials are the driving force for medical innovation and advancements; however, patient enrollment is a critical challenge.
However, despite their importance, participation rates in clinical trials are often low. Several factors contribute to this, creating barriers for both patients and researchers.
Contributing factors:
Lack of Information
The lack of information leads healthcare providers to rely on limited or no information, such as effective dosing regimens and side effects, when treating their minority patients.
Barriers Include:
-
Historical barriers, mistrust, and fear
-
Lack of ethnic minority PIs
-
Lack of ethnic minority coordinators
-
Cultural myths and stereotypes
Limited Patient Data
Limited patient data in underrepresented populations results in the lack of critical knowledge and information of pharmacokinetics and pharmacodynamics.
Courtesy of Michigan Medicine. (2019, February 2). Diversity in Clinical Trials [Video]. Used with permission.
ADVCT is helping to build a better future for clinical research.
By working together, researchers, patients, and healthcare providers can overcome the barriers to clinical trial participation, leading to more effective treatments, improved healthcare outcomes, and a healthier future for everyone.